Company news
Xvivo Perfusion AB news in 2025
Xvivo Perfusion AB's news releases, calls and decks from 2025, newest first.
Interim Report January-September 2025
October 23, 2025
Nomination Committee of XVIVO Perfusion AB (publ)
September 5, 2025
Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation
July 28, 2025
First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist Transport Device
July 21, 2025
Interim Report January-June 2025
July 11, 2025
XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market
June 13, 2025
XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston
April 29, 2025
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
April 25, 2025
Interim Report January-March 2025
April 24, 2025
Calls in 2025
- Xvivo Perfusion (Stockholm:XVIVO) Q3 2025 Earnings Call
Oct 23, 2025
Transcript - Xvivo Perfusion (Stockholm:XVIVO) Q2 2025 Earnings Call
Jul 11, 2025
Transcript - Xvivo Perfusion (Stockholm:XVIVO) Q1 2025 Earnings Call
Apr 24, 2025
Transcript - Xvivo Perfusion (Stockholm:XVIVO) Q4 2024 Earnings Call
Jan 28, 2025
Transcript
Decks in 2025
- Q3 2025 Earnings Presentation
Earnings · 30 slides · Oct 23, 2025
- Q2 2025 Earnings Presentation
Earnings · 24 slides · Jul 11, 2025
- Q1 2025 Earnings Presentation
Earnings · 27 slides · Apr 24, 2025
- Q4 2024 Earnings Presentation
Earnings · 25 slides · Jan 28, 2025